Clinical Trials - OVAREX MAb-B43.13

A multicenter phase IIB clinical trial of OVAREX(TM) MAb-B43.13 for the neo-adjuvant treatment of advanced ovarian cancer

Online application

Clinical Trial
E-mail
By M.D.
-Name of M.D., hospital centre
-Stage and pathology at diagnosis:
-Surgery-radiation-chemotherapy- (#of different regiments)
-Last therapy- data, day, dose, schedule
-Performance status
By Patient
Diagnosis
previous Rx
Current condition

You must have a recent medical summary from your doctor sent to us within the week